IPHA_logo_main_version_h100IPHA_logo_main_version_h100IPHA_logo_main_version_h100IPHA_logo_main_version_h100
  • Home
  • #InnovateForLife
  • News
  • Events
    • IPHA Forum
    • IPHA Annual Conference 2026
    • All other events
  • Publications
    • 2026
      • The Pharmaceutical Sector in Ireland: by Goodbody
      • Irish women’s health in their own words: by Olytico
      • IPHA Framework Agreement 2026-2029
    • 2025
      • Industry’s Role in Shaping Ireland’s Life Science Strategy
      • EFPIA Patients Wait Indicator 2024
      • IPHA Position Paper on Fairer and Faster Access to Medicine
    • 2024
      • EFPIA Patient WAIT Indicator Survey
      • Clinical Trials Agreement
      • Making Ireland a European Leader in Clinical Research
    • 2023
      • Achieving Universal Access to New Medicines for Irish Patients
      • Oireachtas briefing
      • IPHA Policy on Supply Outside Reimbursement Final
      • IPHA Self-Care Infographic
    • 2022
      • IPHA reimbursement timelines analysis 2022
      • Factors Affecting the Location of Biopharmaceutical Investments and Implications for European Policy Priorities
      • IHE Cancer Care Comparator Study
      • White Paper on Enterprise
    • 2021
      • Clinical Trials Survey
      • Cell and Gene Pathfinder Study
      • IPHA Codes of Practice
      • Agreement 2021
    • Pre 2020
      • BioPharma Ambition
      • Manifesto for Better Health
      • Innovation and the IP Framework
      • Self-Care: Taking Charge of Your Health
      • Vaccines For Life
      • Perspectives on Ireland’s Medicines Future
  • Submissions
    • 2025
      • IPHA Submission to Department of Foreign Affairs and Trade EU Presidency 2026
      • IPHA Life Science Strategy Submission Dec 25
      • IPHA Response LSS Consultation final 25
      • RD Incentives Consulation_Final 19 May 25
    • 2024
      • IPHA Submission National Rare Disease Strategy 2024
    • 2023
      • Expert Taskforce Submission September 2023 letter
      • Sinn Fein consultation paper Dec 23
  • Code
    • Codes of Practice
    • Transfers of Value
    • Mandatory notification regarding Advisory Board Meetings
    • IPHA Code Training
    • Complaints
  • Clinical & Regulatory
    • Regulation for Innovation
    • Clinical Trials
    • Medicine Safety
    • Regulatory Science Ireland
    • Counterfeit Medicines
  • Self-Care
  • About
    • Members
    • Board of Directors
    • Media Queries
    • Our Team
    • Affiliates Programme
    • Job Opportunities
  • Home
  • #InnovateForLife
  • News
  • Events
    • IPHA Forum
    • IPHA Annual Conference 2026
    • All other events
  • Publications
    • 2026
      • The Pharmaceutical Sector in Ireland: by Goodbody
      • Irish women’s health in their own words: by Olytico
      • IPHA Framework Agreement 2026-2029
    • 2025
      • Industry’s Role in Shaping Ireland’s Life Science Strategy
      • EFPIA Patients Wait Indicator 2024
      • IPHA Position Paper on Fairer and Faster Access to Medicine
    • 2024
      • EFPIA Patient WAIT Indicator Survey
      • Clinical Trials Agreement
      • Making Ireland a European Leader in Clinical Research
    • 2023
      • Achieving Universal Access to New Medicines for Irish Patients
      • Oireachtas briefing
      • IPHA Policy on Supply Outside Reimbursement Final
      • IPHA Self-Care Infographic
    • 2022
      • IPHA reimbursement timelines analysis 2022
      • Factors Affecting the Location of Biopharmaceutical Investments and Implications for European Policy Priorities
      • IHE Cancer Care Comparator Study
      • White Paper on Enterprise
    • 2021
      • Clinical Trials Survey
      • Cell and Gene Pathfinder Study
      • IPHA Codes of Practice
      • Agreement 2021
    • Pre 2020
      • BioPharma Ambition
      • Manifesto for Better Health
      • Innovation and the IP Framework
      • Self-Care: Taking Charge of Your Health
      • Vaccines For Life
      • Perspectives on Ireland’s Medicines Future
  • Submissions
    • 2025
      • IPHA Submission to Department of Foreign Affairs and Trade EU Presidency 2026
      • IPHA Life Science Strategy Submission Dec 25
      • IPHA Response LSS Consultation final 25
      • RD Incentives Consulation_Final 19 May 25
    • 2024
      • IPHA Submission National Rare Disease Strategy 2024
    • 2023
      • Expert Taskforce Submission September 2023 letter
      • Sinn Fein consultation paper Dec 23
  • Code
    • Codes of Practice
    • Transfers of Value
    • Mandatory notification regarding Advisory Board Meetings
    • IPHA Code Training
    • Complaints
  • Clinical & Regulatory
    • Regulation for Innovation
    • Clinical Trials
    • Medicine Safety
    • Regulatory Science Ireland
    • Counterfeit Medicines
  • Self-Care
  • About
    • Members
    • Board of Directors
    • Media Queries
    • Our Team
    • Affiliates Programme
    • Job Opportunities
  • Home
  • About Us
  • Contact Us

IPHA Conference 2025

  • Home
  • IPHA News
  • Events
  • IPHA Conference 2025
July 22, 2024

The IPHA Annual Conference and dinner will take place at the Dublin Royal Convention Centre on Wednesday 26th February, 2025. Further details will be announced later.

The IPHA conference is open to IPHA members and Affiliates only.

Share

Related posts

March 11, 2024

Highlights from IPHA Conference 7th March 2024


More
March 11, 2024

Minister Donnelly IPHA annual conference 2024


More
March 2, 2023

IPHA Conference 2023 Tánaiste’s speech


More

Terms and Conditions    |    Privacy Statement   |   Sitemap    |    Cookies


Registered Number: 254776    |    Registered Address: 7 Clanwilliam Terrace, Dublin 2, D02 CC64 Ireland   |  Email: info@ipha.ie

© 2024 IPHA